Home › Funds › PSP Research LLC › SUPN
PSP Research LLC position in SUPN
SUPERNUS PHARMACEUTICALS · Health Care
PSP Research LLC reported holding 6,000 shares of SUPN (SUPERNUS PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$258K, representing 0.18% of its reported portfolio and ranking #15 among its reported holdings. PSP Research LLC has disclosed SUPN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How PSP Research LLC's SUPN position evolved
PSP Research LLC first disclosed a stake in SUPN in Q4 2025 at 10,758 shares (US$535K). Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 6,000 shares valued at US$258K. Notable position changes include a 44% trim in Q1 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 10.76K | $534.67K | New |
| Q1 2026 | 6.00K | $310.14K | Reduce |
| Q2 2026 | 6.00K | $279.06K | Hold |
| Q3 2026 | 6.00K | $258.24K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SUPN and 13F data
SUPN (SUPERNUS PHARMACEUTICALS) is a Health Care company. 35 other funds we track also report a position in SUPN — the largest reported positions include MILLENNIUM MANAGEMENT LLC (US$179.2M), ARMISTICE CAPITAL, LLC (US$123.1M), Sofinnova Investments, Inc. (US$48.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SUPN
- MILLENNIUM MANAGEMENT LLC 3.85M sh · $179.21M · Q2 2026
- ARMISTICE CAPITAL, LLC 2.65M sh · $123.07M · Q2 2026
- Sofinnova Investments, Inc. 1.04M sh · $48.20M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 613.78K sh · $28.55M · Q2 2026
- Soleus Capital Management, L.P. 520.00K sh · $24.19M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 490.22K sh · $22.80M · Q2 2026
More on PSP Research LLC
FAQ
How long has PSP Research LLC held SUPN?
PSP Research LLC has disclosed SUPN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is PSP Research LLC's current position in SUPN?
As of Q3 2026, PSP Research LLC holds 6.00K shares of SUPN (SUPERNUS PHARMACEUTICALS), valued at $258.24K, representing 0.18% of its reported portfolio and ranking #15.
Has PSP Research LLC been buying or selling SUPN?
In the latest 13F filing (Q3 2026), PSP Research LLC held unchanged its position in SUPN.
Which other funds hold SUPN?
Other major institutional holders of SUPN include MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Sofinnova Investments, Inc., among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.